July 2006

Editorial board
Published in issue: July 2006
ii

Editorial Comment

160 years of multiple myeloma: Progress and challenges
• Monika Engelhardt,
• Roland Mertelsmann
Published in issue: July 2006
p1507-1509

New Developments in Understanding the Biology and Genetics of Multiple Myeloma

Conventional diagnostics in multiple myeloma
• Jesús F. San Miguel,
• Norma C. Gutiérrez,
• Gema Mateo,
• Alberto Orfao
Published in issue: July 2006
p1510-1519

Cytogenetics and molecular cytogenetics in multiple myeloma
• Peter Liebisch,
• Hartmut Döhner
Published in issue: July 2006
p1520-1529

Genetics and molecular profiling of multiple myeloma: Novel tools for clinical management?
• Pierfrancesco Tassone,
• Pierosandro Tagliaferri,
• Marco Rossi,
• Marco Gaspari,
• Rosa Terracciano,
• Salvatore Venuta
Published in issue: July 2006
p1530-1538
The role of anatomic and functional staging in myeloma: Description of Durie/Salmon plus staging system
• Brian G.M. Durie
Published in issue: July 2006
p1539-1543

Bone markers in multiple myeloma
• Ulrike Heider,
• Claudia Fleissner,
• Ivana Zavrski,
• ...
• Monica Hecht,
• Christian Jakob,
• Orhan Sezer
Published in issue: July 2006
p1544-1553
Myeloma bone disease and treatment options
• Howard S. Yeh,
• James R. Berenson
Published in issue: July 2006
p1554-1563
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactions
• Constantine S. Mitsiades,
• Nicholas S. Mitsiades,
• Nikhil C. Munshi,
• Paul G. Richardson,
• Kenneth C. Anderson
Published in issue: July 2006
p1564-1573

Signalling and survival pathways in multiple myeloma
• Kurt Bommert,
• Ralf C. Bargou,
• Thorsten Stühmer
Published in issue: July 2006
p1574-1580

Angiogenesis in multiple myeloma
• Christian Jakob,
• Jan Sterz,
• Ivana Zavrski,
• ...
• Claudia Fleissner,
• Martin Kaiser,
• Orhan Sezer
Published in issue: July 2006
p1581-1590

Current and Developing Therapies in Multiple Myeloma

State of the art therapy in multiple myeloma and future perspectives
• Ulrich Denz,
• Peter S. Haas,
• Ralph Wäsch,
• Hermann Einsele,
• Monika Engelhardt
Published in issue: July 2006
p1591-1600
Allogeneic haematopoietic cell transplantation for multiple myeloma: Reducing transplant-related mortality while harnessing the graft-versus-myeloma effect
• Robert Zeiser,
• Jürgen Finke
Published in issue: July 2006
p1601-1611

Thalidomide and lenalidomide in the treatment of multiple myeloma
• Shaji Kumar,
• S. Vincent Rajkumar
Published in issue: July 2006
p1612-1622

Proteasome inhibition in multiple myeloma
• Martin Kropff,
• Guido Bisping,
• Doris Wenning,
• Wolfgang E. Berdel,
• Joachim Kienast
Published in issue: July 2006
p1623-1639
Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy
• Malay Chatterjee,
• Tridib Chakraborty,
• Pierfrancesco Tassone
Published in issue: July 2006
p1640-1652
Active immunotherapy of multiple myeloma
• Leonora Houet,
• Hendrik Veelken
Published in issue: July 2006
p1653-1660

Epidemiology and Varia on Multiple Myeloma

Familial risks and temporal incidence trends of multiple myeloma
• Andrea Altieri,
• Bowang Chen,
• Justo Lorenzo Bermejo,
• Felipe Castro,
• Kari Hemminki
Published in issue: July 2006
p1661-1670

Epidemiology and outcomes research for MGUS, myeloma and amyloidosis
• Bhawna Sirohi,
• Ray Powles
Published in issue: July 2006
p1671-1683
An update: Health economics of managing multiple myeloma
• K. Moeremans,
• L. Annemans
Published in issue: July 2006
p1684-1691